Middle East & Africa Benign Prostatic Hyperplasic Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Resectoscopes, Urology Laser, Radiofrequency Ablation Devices, Prostatic Stents, and Implants), Procedure Type (Transur

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,000	126 Pages	The Insight Partners	October, 2022	TIP17492961

Best Price Guarantee
Price	from $3,000
Length	126 Pages
Publisher	The Insight Partners
Published Date	October, 2022
SKU	TIP17492961

Middle East & Africa Benign Prostatic Hyperplasic Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Resectoscopes, Urology Laser, Radiofrequency Ablation Devices, Prostatic Stents, and Implants), Procedure Type (Transurethral Microwave Therapy, Transurethral Resection of the Prostate, Transurethral Needle Ablation of the Prostate, Laser Surgery, Urolift Surgery, and Others), and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

The benign prostatic hyperplasic devices market in the Middle East & Africa is expected to grow from US$ 91.28 million in 2022 to US$ 130.44 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2022 to 2028.
Leading players in the benign prostatic hyperplasic devices market focus on expanding their customer reach across emerging markets in this region by expanding their distribution networks and augmenting manufacturing capabilities. In addition, high investments in life science and healthcare research in emerging countries play a crucial role in the upgrading of the latest technologies in developing countries. Crucial benign prostatic hyperplasic device manufacturers in the Middle East & Africa are expected to witness lucrative opportunities in the future owing to a large patient pool and high benign prostatic hyperplasia prevalence, increasing disposable income, improving healthcare infrastructure, and growing medical tourism in several countries.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa benign prostatic hyperplasic devices market at a substantial CAGR during the forecast period.
Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Benign Prostatic Hyperplasic Devices Market Segmentation

The Middle East & Africa benign prostatic hyperplasic devices market is segmented on the basis of product, procedure type, end user, and country. Based on product, the market is segmented into resectoscopes, urology lasers, radiofrequency ablation devices, prostatic stents, and implants. The resectoscopes segment is expected to hold the largest share of the market in 2022. On the other hand, the urology lasers segment is expected to register the highest CAGR during the forecast period. Based on procedure type, the Middle East & Africa benign prostatic hyperplasic devices market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. The transurethral resection of the prostate segment held the largest market share in 2022, and it is also expected to register the highest CAGR in the market during the forecast period. Based on end user, the Middle East & Africa benign prostatic hyperplasic devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2022, while the clinics segment is expected to register the highest CAGR during the forecast period. Based on country, the Middle East & Africa benign prostatic hyperplasic devices market is segmented into Saudi Arabia, South Africa, the UAE, and Rest of MEA. In 2022, Saudi Arabia held a larger market share. On the other side, and the UAE is expected to register a higher CAGR during the forecast period.
KARL STORZ SE & Co. KG; Olympus Corporation; Boston Scientific Corporation; Teleflex Incorporated; Butterfly; and ProArc are among the leading companies in the Middle East & Africa benign prostatic hyperplasic devices market.

Reasons to buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa benign prostatic hyperplasic devices market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa benign prostatic hyperplasic devices market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the benign prostatic hyperplasic devices market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction: 1.1 Scope of the Study; 1.2 The Insight Partners Research Report Guidance; 1.3 Market Segmentation; 1.3.1 Middle East & Africa Benign Prostatic Hyperplasic Devices Market – By Product; 1.3.2 Middle East & Africa Benign Prostatic Hyperplasic Devices Market – By Procedure Type; 1.3.3 Middle East & Africa Benign Prostatic Hyperplasic Devices Market – By End User; 1.3.4 Middle East & Africa Benign Prostatic Hyperplasic Devices Market – By Country
2. Key Takeaways
3. Research Methodology: 3.1 Coverage; 3.2 Secondary Research; 3.3 Primary Research
4. Middle East & Africa Benign Prostatic Hyperplasic Devices – Market Landscape: 4.1 Overview; 4.2 PEST Analysis; 4.3 Experts Opinion
5. Middle East & Africa Benign Prostatic Hyperplasic Devices Market – Key Market Dynamics: 5.1 Market Drivers; 5.1.1 Widening Prevalence of Benign Prostatic Hyperplasia along with Growing Risk Factors; 5.1.2 Rise in Investments, Funds, and Grants for Research in BPH Treatment; 5.2 Market Restraints; 5.2.1 stringent Awareness of Prostate Health Among Men; 5.3 Market Opportunities; 5.3.1 Emerging Markets; 5.4 Future Trends; 5.4.1 Extending Product Approvals and Launches; 5.5 Impact Analysis
6. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Analysis: 6.1 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue Forecast and Analysis
7. Middle East & Africa Benign Prostatic Hyperplasic Devices Market – by Product: 7.1 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028); 7.2 Resectoscopes; 7.2.1 Overview; 7.2.2 Resectoscopes: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); 7.3 Urology Lasers; 7.3.1 Overview; 7.3.2 Urology Lasers: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); 7.4 Radiofrequency Ablation Devices; 7.4.1 Overview; 7.4.2 Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); 7.5 Prostatic Stents; 7.5.1 Overview; 7.5.2 Prostatic Stents: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); 7.6 Implants; 7.6.1 Overview; 7.6.2 Implants: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Benign Prostatic Hyperplasic Devices Market - by Procedure Type: 8.1 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028); 8.2 Transurethral Microwave Therapy; 8.2.1 Overview; 8.2.2 Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); 8.3 Transurethral Resection of the Prostate; 8.3.1 Overview; 8.3.2 Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); 8.4 Transurethral Needle Ablation of the Prostate; 8.4.1 Overview; 8.4.2 Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); 8.5 Laser Surgery; 8.5.1 Overview; 8.5.2 Laser Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); 8.6 UroLift Surgery; 8.6.1 Overview; 8.6.2 UroLift Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); 8.7 Others; 8.7.1 Overview; 8.7.2 Others: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Benign Prostatic Hyperplasic Devices Market – by End User: 9.1 Overview; 9.2 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028); 9.3 Hospitals; 9.3.1 Overview; 9.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million); 9.4 Clinics; 9.4.1 Overview; 9.4.2 Clinics Market Revenue and Forecast to 2028 (US$ Million); 9.5 Ambulatory Surgical Centers; 9.5.1 Overview; 9.5.2 Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million); 9.6 Others; 9.6.1 Overview; 9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Benign Prostatic Hyperplasic Devices Market – by Country Analysis: 10.1 Overview; 10.1.1 Middle East & Africa: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%); 10.1.1.1 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million); 10.1.1.1.1 Overview; 10.1.1.1.2 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million); 10.1.1.1.3 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million); 10.1.1.1.4 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million); 10.1.1.1.5 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By End User (US$ Million); 10.1.1.2 South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million); 10.1.1.2.1 Overview; 10.1.1.2.2 South Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million); 10.1.1.2.3 South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million); 10.1.1.2.4 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million); 10.1.1.2.5 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million); 10.1.1.3 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million); 10.1.1.3.1 Overview; 10.1.1.3.2 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million); 10.1.1.3.3 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million); 10.1.1.3.4 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million); 10.1.1.3.5 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By End User (US$ Million); 10.1.1.4 Rest of MEA: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million); 10.1.1.4.1 Overview; 10.1.1.4.2 Rest of MEA: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million); 10.1.1.4.3 Rest of Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million); 10.1.1.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million); 10.1.1.4.5 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By End User (US$ Million)
11. Middle East & Africa Benign Prostatic Hyperplasic Devices Market – Industry Landscape: 11.1 Overview; 11.2 Inorganic Growth Strategies; 11.3 Organic Growth Strategies
12. Company Profiles: 12.1 KARL STORZ SE & Co. KG; 12.1.1 Key Facts; 12.1.2 Business Description; 12.1.3 Products and Services; 12.1.4 Financial Overview; 12.1.5 SWOT Analysis; 12.1.6 Key Developments; 12.2 Richard Wolf GmbH; 12.2.1 Key Facts; 12.2.2 Business Description; 12.2.3 Products and Services; 12.2.4 Financial Overview; 12.2.5 SWOT Analysis; 12.2.6 Key Developments; 12.3 Olympus Corporation; 12.3.1 Key Facts; 12.3.2 Business Description; 12.3.3 Products and Services; 12.3.4 Financial Overview; 12.3.5 SWOT Analysis; 12.3.6 Key Developments; 12.4 Boston Scientific Corporation; 12.4.1 Key Facts; 12.4.2 Business Description; 12.4.3 Products and Services; 12.4.4 Financial Overview; 12.4.5 SWOT Analysis; 12.4.6 Key Developments; 12.5 Butterfly; 12.5.1 Key Facts; 12.5.2 Business Description; 12.5.3 Products and Services; 12.5.4 Financial Overview; 12.5.5 SWOT Analysis; 12.5.6 Key Developments; 12.6 Teleflex Incorporated; 12.6.1 Key Facts; 12.6.2 Business Description; 12.6.3 Products and Services; 12.6.4 Financial Overview; 12.6.5 SWOT Analysis; 12.6.6 Key Developments; 12.7 ProArc; 12.7.1 Key Facts; 12.7.2 Business Description; 12.7.3 Products and Services; 12.7.4 Financial Overview; 12.7.5 SWOT Analysis; 12.7.6 Key Developments
13. Appendix: 13.1 About The Insight Partners; 13.2 Glossary of Terms for Middle East & Africa Benign Prostatic Hyperplasia Devices Market
LIST OF TABLES: Table 1. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million); Table 2. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million); Table 3. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million); Table 4. South Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million); Table 5. South Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million); Table 6. South Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million); Table 7. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million); Table 8. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million); Table 9. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million); Table 10. Rest of Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million); Table 11. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million); Table 12. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By End User (US$ Million); Table 13. Recent Inorganic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market; Table 14. Recent Organic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market; Table 15. Glossary of Terms
LIST OF FIGURES: Figure 1. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Segmentation; Figure 2. Middle East & Africa Benign Prostatic Hyperplasic Devices Market, By Country; Figure 3. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Overview; Figure 4. Resectoscopes Segment Held Largest Share of Product Segment in Benign Prostatic Hyperplasic Devices Market; Figure 5. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period; Figure 6. Middle East & Africa Benign Prostatic Hyperplasic Devices Market, Industry Landscape; Figure 7. Middle East & Africa: PEST Analysis; Figure 8. Experts Opinion; Figure 9. Middle East & Africa Benign Prostatic Hyperplasic Devices Market – Revenue Forecast and Analysis – 2020-2028; Figure 10. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028); Figure 11. Resectoscopes: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); Figure 12. Urology Lasers: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); Figure 13. Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); Figure 14. Prostatic Stents: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); Figure 15. Implants: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); Figure 16. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028); Figure 17. Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); Figure 18. Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); Figure 19. Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); Figure 20. Laser Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); Figure 21. UroLift Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); Figure 22. Others: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million); Figure 23. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028); Figure 24. Hospitals Market Revenue and Forecast to 2028 (US$ Million); Figure 25. Clinics Market Revenue and Forecast to 2028 (US$ Million); Figure 26. Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million); Figure 27. Others Market Revenue and Forecast to 2028 (US$ Million); Figure 28. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue Overview, by Country, 2021 (US$ Million); Figure 29. Middle East & Africa: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%); Figure 30. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million); Figure 31. South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million); Figure 32. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million); Figure 33. Rest of MEA: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)